Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pliant Therapeutics, Inc.
- ID
- NCT04396756
- Phase
- Phase 2 Research Study
- Study Type
- Interventional
- Participants
- Expecting 84 study participants
- Last Updated